AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $750,000 | -17.6% | 100,000 | 0.0% | 0.01% | -10.0% |
| Q1 2022 | $910,000 | -67.4% | 100,000 | -51.6% | 0.01% | -74.4% |
| Q4 2020 | $2,791,000 | +13.9% | 206,551 | -0.8% | 0.04% | +5.4% |
| Q3 2020 | $2,451,000 | -20.2% | 208,203 | 0.0% | 0.04% | -21.3% |
| Q2 2020 | $3,073,000 | -4.1% | 208,203 | -12.3% | 0.05% | -26.6% |
| Q1 2020 | $3,206,000 | -20.3% | 237,473 | +42.6% | 0.06% | +20.8% |
| Q4 2019 | $4,025,000 | +26.2% | 166,527 | +0.4% | 0.05% | +15.2% |
| Q3 2019 | $3,189,000 | -12.2% | 165,895 | +35.0% | 0.05% | -2.1% |
| Q2 2019 | $3,632,000 | +2.7% | 122,901 | +25.4% | 0.05% | -7.8% |
| Q4 2018 | $3,538,000 | -37.9% | 98,000 | +16.3% | 0.05% | 0.0% |
| Q2 2018 | $5,694,000 | -65.1% | 84,288 | -72.0% | 0.05% | -62.2% |
| Q1 2018 | $16,335,000 | +100.8% | 301,103 | +121.2% | 0.14% | +107.7% |
| Q4 2017 | $8,134,000 | -12.5% | 136,127 | -28.8% | 0.06% | -5.8% |
| Q3 2017 | $9,296,000 | +194.8% | 191,282 | +218.8% | 0.07% | +165.4% |
| Q2 2017 | $3,153,000 | +161.9% | 60,000 | +125.9% | 0.03% | +160.0% |
| Q1 2017 | $1,204,000 | -69.6% | 26,558 | -74.6% | 0.01% | -69.7% |
| Q4 2016 | $3,960,000 | -21.7% | 104,628 | -21.9% | 0.03% | -29.8% |
| Q3 2016 | $5,055,000 | +879.7% | 133,951 | +437.4% | 0.05% | +327.3% |
| Q3 2014 | $516,000 | -44.2% | 24,927 | -51.6% | 0.01% | -70.3% |
| Q4 2013 | $925,000 | – | 51,508 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |